Updated: Oct 10, 2026

Analyst Stock Ratings

Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Get Alert
Oct 2, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Oct 1, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Aug 18, 2026
ELVNEnliven Therapeutics
$40.98—Get Alert
Aug 18, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Aug 18, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Aug 6, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Aug 6, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Aug 6, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Jul 21, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Jul 9, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Jul 1, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Jun 29, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Jun 9, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Jun 2, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
May 8, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Mar 26, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Mar 25, 2026
ELVNEnliven Therapeutics
$40.98Get Alert
Jul 2, 2025
ELVNEnliven Therapeutics
$40.98Get Alert
Jun 16, 2025
ELVNEnliven Therapeutics
$40.98Get Alert
Jun 16, 2025
ELVNEnliven Therapeutics
$40.98Get Alert
May 16, 2025
ELVNEnliven Therapeutics
$40.98Get Alert
May 15, 2025
ELVNEnliven Therapeutics
$40.98Get Alert
Mar 21, 2025
ELVNEnliven Therapeutics
$40.98Get Alert
Dec 13, 2024
ELVNEnliven Therapeutics
$40.98Get Alert
Nov 15, 2024
ELVNEnliven Therapeutics
$40.98Get Alert
Oct 31, 2024
ELVNEnliven Therapeutics
$40.98Get Alert
Oct 1, 2024
ELVNEnliven Therapeutics
$40.98Get Alert
Sep 9, 2024
ELVNEnliven Therapeutics
$40.98Get Alert
Jun 11, 2024
ELVNEnliven Therapeutics
$40.98Get Alert
Apr 9, 2024
ELVNEnliven Therapeutics
$40.98Get Alert
Mar 29, 2023
ELVNEnliven Therapeutics
$40.98Get Alert
Mar 3, 2023
ELVNEnliven Therapeutics
$40.98—Get Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free